Back to Search
GEORGE WEINER, M.D.
M.D.
Internal Medicine Physician
NPI: 1871553941IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
D0026475(MD)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
STATE UNIVERSITY OF NEW YORK DOWNSTATE MEDICAL CENTER
Class of 1978
Research & Publications (20)
Effectiveness of multi-channel unilateral cochlear implants for profoundly deaf children: a systematic review.
PMID 19531168·Clin Otolaryngol·2009
1-meta
CpG oligonucleotides as immunotherapeutic adjuvants: innovative applications and delivery strategies.
PMID 19166888·Adv Drug Deliv Rev·2009
7-preclinical
CT bronchoscopic simulation for guiding transbronchial needle aspiration of extramural mediastinal and hilar lesions: initial clinical results.
PMID 19244055·Radiology·2009
2-rct
Surgical procedures and non-surgical devices for the management of non-apnoeic snoring: a systematic review of clinical effects and associated treatment costs.
PMID 19091167·Health Technol Assess·2009
1-meta
CpG oligodeoxynucleotide-based therapy of lymphoid malignancies.
PMID 19168102·Adv Drug Deliv Rev·2009
6-review
Measuring granulocyte and monocyte accumulation at malignant lymphoma sites.
PMID 19029411·J Clin Oncol·2009
8-other
Vascular loops causing otological symptoms: a systematic review and meta-analysis.
PMID 18302544·Clin Otolaryngol·2008
1-meta
Complement and cellular cytotoxicity in antibody therapy of cancer.
PMID 18476787·Expert Opin Biol Ther·2008
6-review
The impact of surgical excision in chest wall rhabdomyosarcoma: a report from the Children's Oncology Group.
PMID 18485948·J Pediatr Surg·2008
8-other
Effects of load and indicator type upon occlusal contact markings.
PMID 17618516·J Biomed Mater Res B Appl Biomater·2008
8-other
A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma.
PMID 18927313·Clin Cancer Res·2008
8-other
NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement.
PMID 18024795·Blood·2008
8-other
Computed tomography-bronchoscopic simulation for guiding transbronchial fine needle aspiration of extramural targets: a phantom study.
PMID 18007152·Invest Radiol·2007
8-other
The effects of CpG ODN on CLL proliferation, apoptosis or phenotype could have an impact on its clinical utility.
PMID 17657215·Leukemia·2007
8-other
Time trend analysis of otological procedures performed in England, 1989 to 2005.
PMID 17908351·J Laryngol Otol·2007
4-observational
Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma.
PMID 17947483·Clin Cancer Res·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9512 HARFORD RD
BALTIMORE, MD 21234 - Phone
- (410) 882-0600
Quick Facts
- NPI
- 1871553941
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 48
- Publications
- 20
Are you this provider?
Claim Your Profile